Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex-related differences in fospropofol disodium dose requirement for gastroscope insertion
ChiCTR2500100759Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium and nalbuphine (3 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Modified Observer's Assessment of Alertness/Sedation score and Positive insertion response during gastroscope insertion. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
fospropofol disodiumnalbuphine
Beyond the preview
Go deeper on ChiCTR2500100759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100759.